doi: 10.1161/01.ATV.0000112102.28859.39
© 2004 American Heart Association, Inc.
Editorials |
Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
Correspondence to Donald D. Heistad, MD, ATVB Editorial Office, 609 MRC, Cardiovascular Unit, The University of Iowa, Iowa City, IA 52242. E-mail ATVB{at}uiowa.edu
This editorial continues our tradition of an annual summary of the status of the journal. Our editorship began in the spring of 1999 with goals of publishing high-quality papers, providing authors with timely review and publication of their manuscripts, and of publishing papers of interest to our readers. We will summarize trends during the past year, some changes in the journal, and thank several people for their help.
Publication of High-Quality Papers
In an era in which each of us has enormous difficulty reading all of the important papers in our areas of interest, it is important that experts in some way advise readers which papers are novel and valid. An important mechanism in this process of advising readers is peer review, and attempts by journals to select the most novel valid papers for publication. This process is sometimes painful, because manuscripts are often judged by reviewers and editors to be valid but not of sufficient novelty to be of great interest to readers of the journal.
There is obviously no perfect tool for selection of the most novel manuscripts; reviewers and members of our editorial board advise the editors, who then discuss each manuscript. The process is important because, like discussions at groups that review grant applications, the decisions influence directions of research that are funded and published.
There also is no perfect tool for evaluation of journals, and the quality of papers published in journals. Impact factor, although it is sometimes criticized, is one measure of quality of papers. In some Universities, especially in Europe and Japan, decisions about promotion and tenure are sometimes based in part on impact factor of the journal in which papers are published. Thus, impact factor has assumed greater importance recently, in relation to selection of journals in which authors wish to publish their work.
The impact factor for ATVB again increased substantially this past year (Figure 1), and it has increased more than 50% during the past few years. Because there is a substantial lag-time in impact factor, the large increases in 1999 and 2000 were primarily determined by decisions during the editorship of Dr. Alan Fogelman. Impact factor of other journals in this area of research have fluctuated, but as a group have remained relatively constant (Figure 1). We believe that ATVB is recognized as an appropriate forum for publication of excellent papers related to atherosclerosis, lipoproteins, vascular biology, and thrombosis.
|
We also have tracked the "immediacy index," which provides information about the frequency of references to articles during the first year of their publication. The immediacy index for ATVB has increased substantially in the past few years (Figure 2).
|
Rapid Review and Publication
An important goal is to provide expert, polite, and rapid review of manuscripts that are submitted to the Journal. The average time from receipt of new manuscripts to notification of authors about the first decision has decreased substantially (Figure 3). The review time for Rapid Publication is substantially shorter.
|
Time from acceptance of manuscripts to publication in print has decreased during the past few years (Figure 4). Accepted manuscripts are published electronically (ATVBeFirst), before the print version, within about 7 days after acceptance.
|
The number of manuscripts submitted to the Journal continues to increase steadily (Figure 5). Because this number is now so large, we attempt to protect our Reviewers from reviewing excessive numbers of manuscripts with triage by the Editors. If review by at least two Editors indicates that a manuscript will not be competitive for publication, the manuscript is not sent for review, and is rejected.
|
We wish to express our heart-felt thanks to our All-Star Reviewers, who have reviewed twelve or more papers within 10 days or less: Drs Godfrey Getz, Richard Havel, Lewis Kuller, Philip Barter, Lars Berglund, Jan Breslow, John Crouse, Zvonmir Katusic, Theodore Mazzone, and Renu Virmani. Expeditious, expert reviews clearly are an enormous service to authors, as well as the journal.
Our Constituencies
About half of manuscripts submitted to the journal focus on atherosclerosis and/or lipoproteins. This is an extremely important area of research, and we believe that the Journal is the leading forum for papers in this area of research.
Vascular Biology is a flourishing discipline, and we are attempting to provide a home for manuscripts in this area of research. Although the title of the journal is cumbersome, the name provides for authors and readers a clear definition of topics that are appropriate for the journal. We believe that the title of the journal therefore is useful for authors who are deciding where to send their manuscripts.
Studies of thrombosis, and especially the interaction between blood and blood vessels, are an important part of the journal. Steve Lentz and our editorial staff attended the 2003 meeting of the International Society of Thrombosis and Homeostasis to encourage participants to send their best work to the Journal. We believe that this is a realistic and appropriate goal, based on recent changes in impact factor (Figure 1).
ATVB is the official journal of the ATVB Council of the American Heart Association, the European Vascular Biology Organization, and the Japanese Medical Vascular Biology Association. The link with these organizations provides a strong base of support for the journal.
Overseas Offices
On January 1, 2004, the London office of the journal closed. Professor James Scott, the Editor of the London office for more than 8 years, performed an outstanding job. Professor Scott, his Associate Editors, and the staff were efficient and maintained consistently high standards. We wish to express our sincerest thanks for a great job.
The London office merges with the Stockholm office, as the European office of the Journal. Professor Goran Hansson will continue as the European Editor. Professor Hansson, who will serve this year as Chair of the Nobel Committee for Physiology or Medicine, has impeccable qualifications for judging quality in science!
Professor Akira Takeshita provides great leadership as Asian Editor of ATVB. Because of Professor Takeshita’s efforts, the Journal is now published in Japanese, with support from AstraZeneca, and ATVB is the official Journal of the Japanese Medical Vascular Biology Association.
New Initiatives
Series of Brief Reviews, with Guest Editors, are now published in the journal. The goal of these series, entitled "ATVB in Focus," is to provide timely reviews of topics of special importance. Current "ATVB in Focus" Series are:
- ABC Transporters and Cholesterol Efflux; Alan Tall, Guest Editor
- Extracellular Mediators in Atherosclerosis and Thrombosis; Marschall Runge, Guest Editor
- Non-Invasive Assessment of Atherosclerosis: from Structure to Function; William Haynes, Guest Editor
- Platelet Signal Transduction and Interactions with Vascular Cells; Skip Brass, Guest Editor
- Lipoproteins; James Scott, Guest Editor
- Endothelium; Frank Faraci, Guest Editor
- Smooth Muscle Cell: Developmental Emphasis; Guilio Gabbiani, Guest Editor
- Extracellular Mediators in Atherosclerosis and Thrombosis; Marschall Runge, Guest Editor
There have been rapid advances in electronic tracking systems, for submission of manuscripts, requests and submission of manuscript reviews, tracking of the status of manuscripts, and forwarding of accepted manuscripts for copyediting and printing. The Publishing Committee of the American Heart Association chose to implement a new electronic system, Bench>Press, which will be used by all AHA journals.
ATVB was chosen to implement the new electronic system for all AHA journals. Melissa Shrader and Connie Smith, working especially with Steve Lentz and William Haynes, and with the HighWire staff, brought the system online before the target date and remarkably painlessly. The system will be of substantial help in the process of reviewing and publishing manuscripts.
A "Superfamily" of Risk Factors
I have refrained from using Editorials as a "Bully pulpit" to promote personal crusades. There is, however, a limitation in our understanding of atherosclerosis that I find extremely annoying.
Lists of risk factors (diabetes, male sex, smoking, etc.) are not organized in a logical way. I have proposed1 that we need a "superfamily" of cardiovascular risk factors. The proposal1 "is in part fanciful, and meant to imitate cell and molecular biologists who have extensive, logically organized superfamilies of growth factors, signaling molecules, etc. But more importantly, organization of cardiovascular risk factors by mediator, mechanism, target organ, etc. would provide a framework for better understanding of the diseases. Are there families within the superfamily: eg, mechanical (arterial pressure and pulse pressure) and biochemical (dyslipidemia, hyperhomocystinemia)? What fraction of cardiovascular diseases is accounted for by each of the risk factors (ie, what is the attributed risk)?"
My hope is that readers will respond to this challenge, and provide a great service to scientists and students by providing a structure for understanding risk factors.
Summary
As we begin the fifth year of editorship of the journal (with the term of the current editors continuing until 2007), ATVB seems to be doing well. The impact factor, as a reflection of quality of papers, increased remarkably again this year, and is very strong in comparison with other journals that focus on atherosclerosis, thrombosis, and vascular biology.
The number of manuscripts submitted continues to increase steadily. The time to first decision is short, and papers are published rapidly after acceptance. The Editors sincerely thank the Consulting Editors, members of the Editorial Board, reviewers (please see Acknowledgement to Reviewers at http://atvb.ahajournals.org), authors, and readers of the Journal. We encourage your feedback and advice, sent to atvb@uiowa.edu.
Reference
- Heistad, D. Mikamo Lecture: A Radical View of the "Superfamily" of Cardiovascular Risk Factors. Circ J. 2003; 67: 805–809.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  E. Higashihara, K. Nutahara, S. Horie, S. Muto, T. Hosoya, K. Hanaoka, K. Tuchiya, K. Kamura, K. Takaichi, Y. Ubara, et al. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2847 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kinoshita, N. Matsuda, H. Kaba, N. Hatakeyama, T. Azma, K. Nakahata, Y. Kuroda, K. Tange, H. Iranami, and Y. Hatano Roles of Phosphatidylinositol 3-Kinase-Akt and NADPH Oxidase in Adenosine 5'-Triphosphate-Sensitive K+ Channel Function Impaired by High Glucose in the Human Artery Hypertension, September 1, 2008; 52(3): 507 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Duong, G. L. Weibel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Characterization and properties of pre{beta}-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I J. Lipid Res., May 1, 2008; 49(5): 1006 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Morrisett and K. C. Vickers Vascular Calcification in Homozygote Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 606 - 607. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Reddy, J. P. Bilezikian, S. J. Smith, and L. Mosca Reduced Bone Mineral Density Is Associated with Breast Arterial Calcification J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 208 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Decaudain, M.-C. Vantyghem, B. Guerci, A.-C. Hecart, M. Auclair, Y. Reznik, H. Narbonne, P.-H. Ducluzeau, B. Donadille, C. Lebbe, et al. New Metabolic Phenotypes in Laminopathies: LMNA Mutations in Patients with Severe Metabolic Syndrome J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4835 - 4844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov, I. A. Pavlov, N. Mashtalir, J. L. Nadler, and V. R. Drel High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of "Healthy" Diet and Aldose Reductase Inhibition Diabetes, October 1, 2007; 56(10): 2598 - 2608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kokusho, T. Komaru, S. Takeda, K. Takahashi, R. Koshida, K. Shirato, and H. Shimokawa Hydrogen Peroxide Derived From Beating Heart Mediates Coronary Microvascular Dilation During Tachycardia Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1057 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Villa-Bellosta, Y. E. Bogaert, M. Levi, and V. Sorribas Characterization of Phosphate Transport in Rat Vascular Smooth Muscle Cells: Implications for Vascular Calcification Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1030 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Drouin, N. Thorin-Trescases, E. Hamel, J. R. Falck, and E. Thorin Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries Cardiovasc Res, January 1, 2007; 73(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Czernichow, A. Couthouis, S. Bertrais, A.-C. Vergnaud, L. Dauchet, P. Galan, and S. Hercberg Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 395 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Li, E. E. Sharpe, A. B. Maupin, A. A. Teleron, A. L. Pyle, P. Carmeliet, and P. P. Young VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization FASEB J, July 1, 2006; 20(9): 1495 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Nordsletten, S. Blackett, M. D. Bentley, E. L. Ritman, and N. P. Smith Structural morphology of renal vasculature Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H296 - H309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Fadini, M. Schiavon, M. Cantini, I. Baesso, M. Facco, M. Miorin, M. Tassinato, S. V. d. Kreutzenberg, A. Avogaro, and C. Agostini Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease Stem Cells, July 1, 2006; 24(7): 1806 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Zanotti, F. Poti, E. Favari, K. R. Steffensen, J.-A. Gustafsson, and F. Bernini Pitavastatin Effect on ATP Binding Cassette A1-Mediated Lipid Efflux from Macrophages: Evidence for Liver X Receptor (LXR)-Dependent and LXR-Independent Mechanisms of Activation by cAMP J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 395 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kinoshita, M. Dojo, K. Nakahata, Y. Kimoto, T. Kakutani, K. Mizumoto, and Y. Hatano Augmented activity of adenosine triphosphate-sensitive k+ channels induced by droperidol in the rat aorta. Anesth. Analg., March 1, 2006; 102(3): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rizzo and K. Berneis Low-density lipoprotein size and cardiovascular risk assessment QJM, January 1, 2006; 99(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Pei, J. Gu, P.-R. Thimmalapura, A. Mison, and J. L. Nadler Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E92 - E102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Back, D.-x. Bu, R. Branstrom, Y. Sheikine, Z.-Q. Yan, and G. K. Hansson Leukotriene B4 signaling through NF-{kappa}B-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia PNAS, November 29, 2005; 102(48): 17501 - 17506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ushio-Fukai, L. Zuo, S. Ikeda, T. Tojo, N. A. Patrushev, and R. W. Alexander cAbl Tyrosine Kinase Mediates Reactive Oxygen Species- and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy Circ. Res., October 14, 2005; 97(8): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hu, S. P. RamachandraRao, S. Siva, C. Valancius, Y. Zhu, K. Mahadev, I. Toh, B. J. Goldstein, M. Woolkalis, and K. Sharma Reactive oxygen species production via NADPH oxidase mediates TGF-{beta}-induced cytoskeletal alterations in endothelial cells Am J Physiol Renal Physiol, October 1, 2005; 289(4): F816 - F825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cirillo, P. Golino, P. Calabro, G. Cali, M. Ragni, S. De Rosa, G. Cimmino, M. Pacileo, R. De Palma, L. Forte, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation Cardiovasc Res, October 1, 2005; 68(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zuo, M. Ushio-Fukai, S. Ikeda, L. Hilenski, N. Patrushev, and R. W. Alexander Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1824 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raggi, M. Davidson, T. Q. Callister, F. K. Welty, G. A. Bachmann, H. Hecht, and J. A. Rumberger Aggressive Versus Moderate Lipid-Lowering Therapy in Hypercholesterolemic Postmenopausal Women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES) Circulation, July 26, 2005; 112(4): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bang, L. Marnell, C. Mold, M.-P. Stein, K. T. D. Clos, C. Chivington-Buck, and T. W. D. Clos Analysis of Binding Sites in Human C-reactive Protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by Site-directed Mutagenesis J. Biol. Chem., July 1, 2005; 280(26): 25095 - 25102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Melse-Boonstra, P. I Holm, P. M Ueland, M. Olthof, R. Clarke, and P. Verhoef Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1378 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cunningham, D. Swartzlander, S. Liyanarachchi, R. V. Davuluri, and G. E. Herman Changes in gene expression associated with loss of function of the NSDHL sterol dehydrogenase in mouse embryonic fibroblasts J. Lipid Res., June 1, 2005; 46(6): 1150 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Merhi-Soussi, B. R. Kwak, D. Magne, C. Chadjichristos, M. Berti, G. Pelli, R. W. James, F. Mach, and C. Gabay Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice Cardiovasc Res, June 1, 2005; 66(3): 583 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hopkins Tissue Engineering of Heart Valves: Decellularized Valve Scaffolds Circulation, May 31, 2005; 111(21): 2712 - 2714. [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Fadini, M. Miorin, M. Facco, S. Bonamico, I. Baesso, F. Grego, M. Menegolo, S. V. de Kreutzenberg, A. Tiengo, C. Agostini, et al. Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1449 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Bates and W. C. Lau Controversies in Antiplatelet Therapy for Patients With Cardiovascular Disease Circulation, May 3, 2005; 111(17): e267 - e271. [Full Text] [PDF]
|
|
|
|
|
|
O. D. Defawe, R. D. Kenagy, C. Choi, S. Y.C. Wan, C. Deroanne, B. Nusgens, N. Sakalihasan, A. Colige, and A. W. Clowes MMP-9 regulates both positively and negatively collagen gel contraction: A nonproteolytic function of MMP-9 Cardiovasc Res, May 1, 2005; 66(2): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Trebino, J. D. Eskra, T. S. Wachtmann, J. R. Perez, T. J. Carty, and L. P. Audoly Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages J. Biol. Chem., April 29, 2005; 280(17): 16579 - 16585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Boekholdt, T. T. Keller, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, M. S. Sandhu, J. W. Jukema, J. J.P. Kastelein, C. E. Hack, et al. Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 839 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tobias and L. K. Curtiss Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J. Lipid Res., March 1, 2005; 46(3): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M. Touyz, G. Yao, M.T. Quinn, P.J. Pagano, and E.L. Schiffrin p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yada, H. Shimokawa, O. Hiramatsu, T. Kajita, F. Shigeto, E. Tanaka, Y. Shinozaki, H. Mori, T. Kiyooka, M. Katsura, et al. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo J. Am. Coll. Cardiol., February 15, 2005; 45(4): 599 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Peterson and Z. S. Katusic Transcribing the Cross-Talk of Cytokine-Induced Tetrahydrobiopterin Synthesis in Endothelial Cells Circ. Res., February 4, 2005; 96(2): 141 - 143. [Full Text] [PDF]
|
|
|
|
|
|
A. Undas, K. E. Brummel-Ziedins, and K. G. Mann Statins and Blood Coagulation Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Yasmin, S. Wallace, C. M. McEniery, Z. Dakham, P. Pusalkar, K. Maki-Petaja, M. J. Ashby, J. R. Cockcroft, and I. B. Wilkinson Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang and B. Paigen Genetics of Variation in HDL Cholesterol in Humans and Mice Circ. Res., January 7, 2005; 96(1): 27 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, S. E. Kelemen, and M. V. Autieri Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration Am J Physiol Cell Physiol, January 1, 2005; 288(1): C81 - C88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Z. Kong, X.-R. Huang, X. Ouyang, J.-J. Tan, G. Fingerle-Rowson, M. Bacher, W. Mu, L. A. Scher, L. Leng, R. Bucala, et al. Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques Cardiovasc Res, January 1, 2005; 65(1): 272 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schmidt, C. Breymann, A. Weber, C. I. Guenter, S. Neuenschwander, G. Zund, M. Turina, and S. P. Hoerstrup Umbilical Cord Blood Derived Endothelial Progenitor Cells for Tissue Engineering of Vascular Grafts Ann. Thorac. Surg., December 1, 2004; 78(6): 2094 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamamoto, T. Kondo, S. Suzuki, H. Izawa, M. Kobayashi, N. Emi, K. Komori, T. Naoe, J. Takamatsu, and T. Murohara Molecular Evaluation of Endothelial Progenitor Cells in Patients With Ischemic Limbs: Therapeutic Effect by Stem Cell Transplantation Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): e192 - e196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kamimura, F. Bea, T. Akizawa, H. A. Katus, J. Kreuzer, and C. Viedt Platelet-Derived Growth Factor Induces Tissue Factor Expression in Vascular Smooth Muscle Cells via Activation of Egr-1 Hypertension, December 1, 2004; 44(6): 944 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. de Grooth, A. H. E. M. Klerkx, E. S. G. Stroes, A. F. H. Stalenhoef, J. J. P. Kastelein, and J. A. Kuivenhoven A review of CETP and its relation to atherosclerosis J. Lipid Res., November 1, 2004; 45(11): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Ory Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis: Have the Orphans Found a Home? Circ. Res., October 1, 2004; 95(7): 660 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|